- Bio-Hackers Invented Open Insulin to Get Around Soaring Drug Prices. But Don’t Bet on It Arriving in Pharmacies SoonBio-hacking is maturing and may soon run up against the FDA.
- This Drug Company Is Making Obesity Its No. 1 PriorityNovo Nordisk is insuring itself against a price clampdown on its diabetes products
- This Drug Company Just Made a Huge Pledge on Its PricesSanofi is going a step further than other drug makers.
- Johnson & Johnson Is Dialing Down Crazy Drug Price HikesAfter more than a year of public shaming.
- This Pharma Giant Just Pulled Back the Curtain On Its Drug Price HikesMerck just released a whole lot more information about its practices.
- Trump Is 'Doomed to Fail,' Says EU Trade ChiefBut a U.S.-EU trade deal is nonetheless "in the freezer."
- 5 Major Trends That Shaped Biopharma's 2016From drug pricing to CEO shake-ups.
Skip to Content